The Bio Report: Taking a Portfolio Approach to Immuno-Oncology Media CoverageBy Portage Biotech, IncAugust 5, 2021...
Empowered Patient Podcast: Stimulating Invariant Natural Killer T-Cells to Boost Immune System in Fight Against Cancer Media CoverageBy Portage Biotech, IncMay 25, 2021...
Portage Biotech Begins Phase I Trial of Invariant Natural Killer T-Cell Therapy Media CoverageBy walidApril 8, 2021...
Juvenescence CEO reveals why its deal with Portage is the smart choice for its longevity IP portfolio Media CoverageBy walidMarch 9, 2021...
CEO Ian Walters Discusses Expectations for Portage Biotech (PRTG) Pipeline Media CoverageBy walidMarch 3, 2021...
Portage Biotech to begin trading its shares on the Nasdaq February 25th Media CoverageBy walidFebruary 22, 2021...
CEO Spotlight: Portage Biotech CEO Dr. Ian Walters Talks Asset Pipeline, Uplist, and Strategic Initiatives in a $20 Billion Sector Media CoverageBy walidDecember 1, 2020...
